I
n the mammalian brain, dendritic spines make most excitatory synapses. During development, synapse formation and elimination are accompanied by changes in dendritic spine number and morphology, allowing the establishment and remodelling of neuronal circuits. Structural plasticity of dendritic spines is tightly correlated with synaptic function and plasticity; even subtle changes in dendritic spines may have marked effects on synaptic plasticity. In particular, a large number of brain disorders, including developmental disorders are accompanied by disease-related changes in dendritic spine density and/or morphology.
Tuberous sclerosis complex (TSC) is a systemic genetic disease that causes the growth of hamartomas in the brain and other organs 1 . The neurological symptoms of TSC include mental retardation, intractable epilepsy, and autism 1 . TSC results from inactivating mutations in either Tsc1 2 or Tsc2 3 , which encode hamartin and tuberin, respectively. Hamartin and tuberin form a complex that exhibits guanosine triphosphatase (GTPase)-activating protein (GAP) activity toward Rheb, a Ras-like small G-protein [4] [5] [6] . Inactivating mutations in Tsc1 or Tsc2 result in the accumulation of the GTP-bound form of Rheb, which activates mammalian target of rapamycin complex 1 (mTORC1) 7 . The mTOR is a serine/threonine protein kinase that stimulates translation initiation processes involving both eIF4E/4E-binding protein (4EBP) and p70S6 kinase/ribosomal S6 protein.
Mouse models that harbor a mutation in the Tsc1 or Tsc2 genes have been extensively investigated to clarify the mechanisms of the pathogenesis of TSC. Several lines of evidence suggest that these TSC model mice exhibit impairments in dendritic spine formation 8 , long-term depression and cognitive behaviors 9 , suggesting that activation of mTORC1 in TSC neurons may cause memory disturbance probably through dendritic spine abnormalities. However, the mTOR signaling has been demonstrated to be activated during learning and is required for spatial memory formation 10 . This controversy may suggest that another mechanism other than the mTOR signaling could be involved in memory impairment in TSC.
In the present study, we first confirmed that dendritic spine formation was abrogated and also excitatory spine synapses were drastically reduced in cultured rat Tsc2 1/2 neurons. This observation was consistent with the finding that filopodia-like protrusions were increased in Tsc2 1/2 rat brain. We treated cultured Tsc2 1/2 neurons with rapamycin, a specific mTORC1 inhibitor; however, it did not restore spine morphology but rather elongated dendritic protrusions. Knockdown of mTOR did not restore spine synapse formation either, suggesting that the mTORC pathway may not participate in spine synapse morphogenesis. We therefore focused on Rheb upstream of mTORC1, and expressed the GDP-bound form of Rheb in Tsc2 1/2 neurons, resulting in restoration of spine synapse formation. Conversely, expression of the GTP-bound Rheb abolished spine formation in WT neurons. Furthermore, treatment with farnesyl transferase inhibitors (FTIs) lonafarnib and tipifarnib also rescued spine synapse formation in Tsc2 1/2 neurons. Taken together, these results suggest that spine synapse deformity in TSC neurons may be dependent on the state of Rheb, but not on mTORC activation.
Results

Tsc2
1/2 neurons show impaired spine synapse formation. In this study, we used spontaneous Tsc2-mutated Eker rats as animal models of TSC 11 . We first compared dendritic spine morphology of cultured hippocampal neurons of wild type (WT) and heterozygous Eker (Tsc2
) rats. At 21 days in vitro (DIV), the dendritic spines of WT neurons displayed mushroom-type spines (Fig. 1a)(top) , whereas the dendrites of Tsc2 1/2 neurons possessed long, thin filopodia (Fig. 1a) (bottom). Quantification showed the Tsc2 mutation reduced the width of dendritic protrusions (Fig. 1a,  b ) and increased their length (Fig. 1a, c) . To assess the influence of Tsc2 haploinsufficiency on spine synapse formation, we immunolabelled neurons with vesicular glutamate transporter 1 (vGlut1), a presynaptic excitatory marker. In Tsc2 1/2 neurons, dendritic vGlut1 puncta were rarely located on protrusions but preferentially localized to dendritic shafts (Fig. 1a, d , e), indicating that Tsc2 1/2 growth cones form synapses with dendritic shafts. Next, to confirm whether dendritic protrusions of in vivo Tsc2 1/2 neurons exhibit similar morphological changes to those in cultured Tsc2
1/2 neurons, we labeled hippocampal CA1 neurons in WT and Tsc2 1/2 fixed brain tissues with biolistic-DiI (Fig. 1f) . We observed similar morphological changes in spine width and length in Tsc2 1/2 neurons in vivo (Fig. 1g, h ) to those observed in cultured Tsc2 1/2 neurons.
The mTORC1 inhibitor rapamycin does not restore spine synapse morphogenesis in Tsc2 1/2 neurons. To address whether the effects of Tsc2 haploinsufficiency on neuronal morphology are mediated by elevated mTORC1 activity, we examined the ability of rapamycin to reverse defects in neuronal morphology. WT and Tsc2
1/2
hippocampal neurons were treated with rapamycin and maintained for 6 days. Application of rapamycin to Tsc2 1/2 neurons completely abolished the phosphorylation of S6 ribosomal protein, which is a substrate of the mTORC1 downstream target S6 kinase 12 ( Fig. 2a, Supplementary Fig. S4a, b) . Although rapamycin did not affect spine morphology in WT neurons (Fig. 2b, c, d ), it rather induced the growth of long, thin protrusions in Tsc2 (Fig. 2b, c, d ) without restoration of spine synapse formation (Fig. 2b, e, f) . To test whether mTORC2 participates in spine synapse formation, we next knocked down mTOR in WT and Tsc2 1/2 neurons by genetic silencing with siRNA ( Supplementary  Fig. S1 ). However, mTOR siRNA did not reverse spine synapse formation but rather elongated dendritic protrusions in Tsc2 1/2 neurons, like rapamycin treatment (Fig. 2g-k) . The mTOR inhibition by either rapamycin or siRNA did not significantly change the number of spine synapses (Fig. 2e, f, j, k) . Thus, neither mTORC1 nor mTORC2 may participate in the impaired spine synapse morphogenesis in TSC neurons.
Inactivation of Rheb recovers spine synapse formation in Tsc2 Supplementary  Fig. S2a, b) . Gln64 mutant of Rheb displays a higher basal GTP level 5 , whereas Rheb D60I mutation interferes selectively with GTP binding 13 . Expression of the Rheb Q64V completely abolished spine synapse formation in WT neurons, whose dendritic morphology was similar to that of Tsc2 1/2 neurons ( Fig. 3a-e) . In contrast, Rheb Q64V expression did not affect filopodia-like morphology of dendritic protrusions in Tsc2 1/2 neurons (Fig. 3a-c) . Conversely, the expression of Rheb D60I restored spine synapse formation in Tsc2 1/2 neurons by increasing the ratio of spine synapses (Fig. 3f , i, j). Rheb D60I expression also rescued spine width in Tsc2 1/2 neurons to a similar extent to those in WT neurons (Fig. 3f, g ). However, overexpression of Rheb D60I in WT neurons differentially modified their spine structure from those of Tsc2 1/2 neurons. Rheb D60I expression unexpectedly caused narrower and longer dendritic protrusions (Fig. 3f , g, h), and reduced the ratio of spine synapses in WT neurons (Fig. 3f, neurons. On the other hand, either lonafarnib or tipifarnib treatment did not affect spine synapse formation in WT neurons (Fig. 4c, f, g ). In conclusion, persistent activation of Rheb may abolish dendritic spine morphogenesis and that inactivation of Rheb with FTI may restore spine synapse formation in TSC neurons.
Finally, to reveal the functional differences in excitatory synaptic transmission between WT and Tsc2 1/2 neurons, we measured evoked EPSC amplitude, mEPSC amplitude/frequency, readily releasable pool size and vesicular release probability from both cultured neurons. However, unexpectedly, synaptic transmission was sufficiently observed in cultured Tsc2 1/2 neurons without any significant difference in presynaptic or postsynaptic features between WT and Tsc2 1/2 neurons (Supplementary Fig. S3a-f ). These results suggest that basal synaptic transmission may be preserved in Tsc2 1/2 neurons as WT neurons, irrespective of spine synapse abnormalities. Other electrophysiological properties, such as long-term depression, might be affected by impaired spine morphogenesis in Tsc2 1/2 neurons. Further studies are necessary for understanding the effects of morphological abnormalities of dendritic spines on the pathogenesis of TSC.
Discussion
In this paper, we have demonstrated activation of Rheb, not of mTORC1, is a main cause of dendritic spine synapse abnormality in Tsc2 1/2 neurons. We showed that active Rheb mutant abolished spine formation in WT neurons, whereas the inactive mutant of Rheb restored spine synapse morphogenesis in Tsc2 1/2 neurons. Furthermore, we demonstrated that FTI treatment, but not rapamycin treatment, rescued spine synapse morphology in Tsc2 1/2 neurons. These results, taken together, suggest that Rheb inhibition by FTI may be necessary for recovery of spine synapse formation in the TSC brain. Mouse models of TSC have demonstrated dendritic spine abnormalities that are resistant to rapamycin treatment 8, 16 . For example, Tsc1-deficient mice develop several pathological features observed in human TSC patients. Rapamycin treatment improved neurofilament abnormalities, myelination and cell enlargement in Tsc1-ablated neurons, but it did not reverse dendritic spine morphology 17 . Additional studies have revealed that the application of rapamycin to Tsc1-or Tsc2-reduced neurons did not restore spine formation 8 . Factin is the major cytoskeletal component in dendritic spines and has been thought to provide the structural basis for dendritic spines 18 . However, rapamycin has been shown to rather suppress F-actin reorganization in an mTOR-dependent manner [18] [19] [20] . Therefore, inhibition of F-actin reorganization by rapamycin might cause an elongation of existing filopodial protrusions, consistent with our results. Taken together, the impaired spine formation in TSC neurons may not be mediated by mTORC1.
Our results indicate that FTI treatment could restore morphological abnormalities in Tsc2 1/2 neurons. Farnesyl transferase (FT) recognizes the carboxyl-terminal CAAX box of small GTP-binding proteins and catalyses the transfer of lipid onto the cysteine residue.
Following carboxymethylation of the farnesyl cysteine renders the carboxyl terminus more hydrophobic 21 . Membrane localization is essential for Rheb activity as for other small GTP-binding proteins 22 .
To prevent Rheb farnesylation and membrane localization, FTIs have been used 14, 23 . Unlike Ras, Rheb is not a substrate for geranylgeranyltransferases and can only undergo farnesylation 14 . Therefore, FTIs may suppress the Rheb activity mainly. On the other hand, another small GTP-binding protein RhoB has been shown to be an additional target of FTIs 24, 25 . Because FTI treatment induces apoptosis in the endothelial cells of sprouting and developing blood vessels via inhibition of RhoB 25 , pharmaceutical inactivation of RhoB could cause possible side effects as cardiovascular disorders where the angiogenesis would be desirable.
The finding that FTI was capable of restoring dendritic spine formation suggests that there are two different pathways downstream of Rheb in neurons, one signalling to neuronal growth and the other regulating neuronal morphology. The pathway affecting growth is likely to be mTORC1-dependent, whereas the pathway regulating neuronal morphology is rapamycin-insensitive. This mTORC1-dependent signalling is activated during learning and plays a crucial role in the spatial learning 10 . By contrast, the TSC mice develop significant cognitive deficits 9 . This discrepancy might be explained by the notion that activation of the mTORC1-independent signalling may impair spine synapse formation in TSC and dominantly disturb memory acquisition or retention despite the mTORC1 activation.
What could be involved in the mTORC1-independent pathway to control neuronal morphology? We initially considered the possibility of the mTORC2 pathway; however, this seems unlikely, because mTOR knockdown fails to reverse spine synapse formation in Tsc2 1/2 neurons (Fig. 2g-k) . Further experiments may provide important insights into how Rheb regulates neuronal morphology.
As Rheb-mediated regulation of cytoskeleton has not been reported so far, we are currently searching Rheb-binding protein(s) in neurons. Clarification of this mechanism could extend our understanding of the prevailing role of Rheb in memory impairments in TSC patients.
Methods
Reagents. Rapamycin and FTIs (lonafarnib and tipifarnib) were purchased from LKT Laboratories and Toronto Research Chemicals, respectively. The used siRNAs are as follows: mTOR siRNA (CAGCAGCUGGUACAUGACAAGUACU and 
Animals. The Eker (Tsc2
1/2
) and wild-type (WT) genotypes were determined using PCR 26 . All animal experiments were approved by the Committee on the the Animal Care and Use Committees of the Tokyo Metropolitan Institute of Medical Science and Fukuoka University, and were performed according to their recommendation.
Primary culture and transfection. Primary culture and transfection of hippocampal neurons from Tsc2 1/2 and WT littermates (E20) have been previously described [27] [28] [29] . Cultured neurons were maintained in Neurobasal Medium supplemented with B27, gentamicin and GLUTAMAX. The neurons were transfected at DIV11-12 using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cultured hippocampal neurons were treated with 100 nM rapamycin for 6 days, 2 mM lonafarnib or 2 mM tipifarnib for 3 days. All experiments comparing WT and Tsc2 1/2 neurons were performed in parallel. Spine and/or shaft synapse density analysis were performed as described previously 30 . Spines were defined as any protrusions from the dendritic shaft ,8 mm in length. The number of vGlut1 puncta on spine and shaft synapses of the dendritic segment is determined by counting the number of vGlut1 puncta that are partially overlapping to the GFP-positive shaft or spines. Any vGlut1 puncta that are not touching the GFP-positive dendrite are not included.
Immunostaining. Rat cultured hippocampal neurons were fixed with 4% paraformaldehyde, blocked, permeabilized with BL solution (3% normal goat serum or 3% bovine serum albumin with 0.1% Triton X-100 in PBS), and incubated overnight at 4uC with one of the following primary antibodies: anti-GFP (chicken, Millipore), anti-phospho S6 (Ser235/236) (rabbit, CST), anti-phospho-Akt (Ser473) (rabbit, CST) or anti-vGlut1 (guinea pig, Millipore). The immunoreactivity was visualized using species-specific, fluorochrome-conjugated secondary antibodies. Neuronal F-actin was visualized by staining with Alexa Fluor 647 phalloidin (Invitrogen).
Image acquisition and quantification. Confocal images of neurons were obtained using a Zeiss 633 lens (NA 1.4) with sequential acquisition settings at the resolution of the confocal microscope (512 3 512 pixels). Each image was a composite constructed from a series of images captured throughout the z aspect of each cell. The parameters of each composite image were optimized for the particular lens and pinhole setting. Identical confocal microscope settings were maintained for all scans in each experiment. All morphometric analyses and quantifications were performed using MetaMorph image analysis software (Universal Imaging). For the spine morphology studies, individual dendritic protrusions were manually traced, and the maximum length and head width of each dendritic protrusion were measured and recorded in Microsoft Excel.
Diolistic labelling. Eight-week-old rats were deeply anesthetized with 0.1 mg/kg phenobarbital perfused transcardially with 0.1 M PB, followed by 50 ml of 2% PFA. The brains were dissected and post-fixed in the same fixative for 4 hr. Subsequently, sagittal brain sections were obtained using a vibratome and collected in PBS. Twentyfive milligrams of gold particles (Bio-Rad) were coated with 7.0 mg of the lipophilic dye DiI (Invitrogen) and injected into Tefzel tubing, which was subsequently cut into bullets. These particles were delivered diolistically at 80 psi using a Helios gene-gun system (Bio-Rad). The slices were fixed again with 4% PFA at 4uC for 1 hr and mounted on slides in VectaShield Mounting Medium (Vector Laboratories).
Western blot analysis. Western blot analyses of rat hippocampal neurons with antiphospho S6 (Ser235/236) (rabbit, CST) antibody 31 , anti-S6 (rabbit, CST) antibody 32 or HEK 293T cells with anti-mTOR antibody 33 were performed as described previously 29 .
Autaptic culture. Astrocytes were obtained from cerebral cortices of newborn (P0) ICR mice (Kyudo). Cerebral cortices were removed from the brains, placed in cold Hank's Balanced Saline Solution (HBSS, Invitrogen) and dissociated with 0.05% trypsin-EDTA (Wako). The cells were plated in plating medium composed of Dulbecco's Modified Eagle Medium with GLUTAMAX and pyruvate (DMEM, Invitrogen) supplemented with 10% fetal bovine serum (FBS, Invitrogen) and 0.1% MITO1 Serum Extender (BD Biosciences). Two weeks later, astrocytes adhered to the bottom of the culture bottle were trypsinized and plated onto microdot-coated coverslips at a density of 6,000 cells/cm 2 . The autaptic cultures of E18-19 hippocampal neurons were generated in accordance with previous reports [34] [35] [36] . Briefly, CA1-CA3 hippocampi were isolated from embryo rats and enzymatically dissociated in papain (2 units/ml, Worthington) in DMEM. The dissociated hippocampal neurons were plated at a density of 1,500 cells/ cm 2 onto the above astrocyte island plates. Before plating the dissociated neurons, the astrocyte-conditioned media was exchanged for Neurobasal-A medium (Invitrogen) supplemented with 2% B27 supplement (Invitrogen) and GLUTAMAX.
Electrophysiology. Synaptic responses from WT and Tsc2 1/2 autaptic neurons were recorded in the whole-cell configuration under the voltage-clamp mode at a holding potential (Vh) of 270 mV (MultiClamp 700B, Molecular Devices) and room temperature. The patch pipette resistance was 3-5 MV, and a series resistance was compensated by 70-90%. The AMPA receptor-mediated evoked glutamatergic synaptic transmission was recorded in response to an action potential elicited through a brief (2 ms) somatic depolarization pulse (to 10 mV) from the patch pipette. Spontaneous glutamatergic mEPSCs were recorded in the presence of 0.5 mM tetrodotoxin (TTX). The size of the readily releasable pool (RRP) of synaptic vesicles was estimated using a synaptic transient charge elicited through a 10 sec application of 0.5 M sucrose. The number of synaptic vesicles in the RRP was subsequently calculated by dividing the RRP charge by an individual average mEPSC charge. The vesicular release probability (P vr ) was calculated as the ratio of the charge of the evoked EPSC to the RRP charge successfully obtained from the same neuron. The synaptic responses were recorded at a sampling rate of 20 kHz and filtered at 10 kHz. The template for the mEPSC data analysis was set as a rise time constant of 0.5 ms, a decay time constant of 4 ms, a baseline of 5 ms, and a template length of 10 ms. The data were analysed off-line using Axograph X 1.2 software (AxoGraph Scientific). Recordings of synaptic responses were performed at DIV 7-9 for immature synapses and at DIV 19-22 for mature synapses.
The standard extracellular solution contained (in mM) NaCl 140, KCl 2.4, HEPES 10, glucose 10, CaCl 2 2, and MgCl 2 1, with pH 7.4 and an adjusted osmotic pressure of 315-320 mOsm. Patch pipettes were filled with an intracellular solution containing (in mM) K-gluconate 146.3, MgCl 2 0.6, ATP-Na 2 4, GTP-Na 2 0.3, phosphocreatine 12, EGTA 1, and HEPES 17.8, as well as creatine phosphokinase 50 U/ml (pH 7.4). The extracellular solutions were applied using a fast-flow application system (Warner Instruments). All chemicals were purchased from Sigma-Aldrich unless otherwise specified.
Statistical analysis. The data were statistically analysed using Student's t-test, twoway ANOVA or the Kolmogorov-Smirnov test. Differences were considered significant when p , 0.05.
